产品名称
依那西普, European Pharmacopoeia (EP) Reference Standard
grade
pharmaceutical primary standard
API family
etanercept
manufacturer/tradename
EDQM
application(s)
pharmaceutical
format
neat
正在寻找类似产品? 访问 产品对比指南
Application
This product is intended for laboratory tests as prescribed in the EP only. Established for use with the monograph(s): 2895.
General description
Etanercept is one of the biologic disease-modifying anti-rheumatic drugs (DMARDs) used to treat rheumatoid arthritis (RA). It acts as a tumor necrosis factor (TNF) antagonist by binding with TNF cytokine or protein, thereby blocking its interaction with cell surface receptors. Thus, etanercept effectively relieves joint inflammation from RA and lowers the disease activity.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
Other Notes
Sales restrictions may apply.
Packaging
The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
监管及禁止进口产品
此项目有
Etanercept
European Pharmacopoeia Commission and Directorate for the Quality of Medicines & Healthcare
European pharmacopoeia, 4979-4983 (2021)
Development of a sensitive enzyme-linked immunosorbent assay for the measurement of biologically active etanercept in patients with ankylosing spondylitis
Wang L, et al.
Journal of Chromatography. B, Biomedical Applications, 1008, 219-224 (2016)
Characterization and application of a unique panel of monoclonal antibodies generated against etanercept
Detrez I, et al.
Journal of Immunology, 196(6), 2879-2884 (2016)
Etanercept concentration in patients with rheumatoid arthritis and its potential influence on treatment decisions: a pilot study
Daien CI, et al.
The Journal of Rheumatology, 39(8), 1533-1538 (2012)
Rheumatiod Arthritis: An Updated Overview of Latest Therapy and Drug Delivery
Kesharwani D, et al.
Journal of pharmacopuncture, 22(4), 210-224 (2019)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持